Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 8/20 | 0.38 |
| ▸ | BACE1 | P56817 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 7/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.35 |
| ▸ | F2 | P00734 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL435199 | 0.81 | CYP4F2 (0.47) | CNR2CNR1 | |
| SCHEMBL5106706 | 0.80 | F2 (0.41) | CNR2CNR1F2 | |
| SCHEMBL8142072 | 0.76 | TYR (0.43) | CNR2CNR1 | |
| SCHEMBL4392674 | 0.75 | CSNK2A1 (0.41) | — | |
| SCHEMBL8146596 | 0.72 | ALOX5 (0.59) | CNR2CNR1 | |
| SCHEMBL4390974 | 0.69 | CSNK2A1 (0.47) | — | |
| SCHEMBL5017455 | 0.68 | ALDH1A1 (0.45) | BACE1 | |
| SCHEMBL5106761 | 0.68 | CNR2 (0.46) | CNR2CNR1 | |
| SCHEMBL5015511 | 0.67 | POLB (0.51) | CNR2CNR1F2 | |
| SCHEMBL7726674 | 0.66 | MAOB (0.59) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11717514-B2 | PSMA binding ligand-linker conjugates and methods for using | PURDUE RESEARCH FOUNDATION (US) | 2023-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11717514-B2 | PSMA binding ligand-linker conjugates and methods for using | FOLH1, KLK3, PSMA1 | CNR2 3085/4885BACE1 2024/4885CNR1 2774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.